LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 243

Search options

  1. Article ; Online: Endothelial lipase variant T111I does not alter inhibition by angiopoietin-like proteins.

    Sylvers-Davie, Kelli L / Bierstedt, Kaleb C / Schnieders, Michael J / Davies, Brandon S J

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 4246

    Abstract: High levels of HDL-C are correlated with a decreased risk of cardiovascular disease. HDL-C levels are modulated in part by the secreted phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL and decreases circulating HDL-C ... ...

    Abstract High levels of HDL-C are correlated with a decreased risk of cardiovascular disease. HDL-C levels are modulated in part by the secreted phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL and decreases circulating HDL-C concentrations. A 584C/T polymorphism in LIPG, the gene which encodes EL, was first identified in individuals with increased HDL levels. This polymorphism results in a T111I point mutation the EL protein. The association between this variant, HDL levels, and the risk of coronary artery disease (CAD) in humans has been extensively studied, but the findings have been inconsistent. In this study, we took a biochemical approach, investigating how the T111I variant affected EL activity, structure, and stability. Moreover, we tested whether the T111I variant altered the inhibition of phospholipase activity by angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4), two known EL inhibitors. We found that neither the stability nor enzymatic activity of EL was altered by the T111I variant. Moreover, we found no difference between wild-type and T111I EL in their ability to be inhibited by ANGPTL proteins. These data suggest that any effect this variant may have on HDL-C levels or cardiovascular disease are not mediated through alterations in these functions.
    MeSH term(s) Humans ; Angiopoietin-Like Protein 3 ; Angiopoietin-like Proteins/genetics ; Angiopoietins ; Cardiovascular Diseases ; Cholesterol, HDL/metabolism ; Lipase/genetics ; Lipase/metabolism ; Phospholipases
    Chemical Substances Angiopoietin-Like Protein 3 ; Angiopoietin-like Proteins ; Angiopoietins ; ANGPTL3 protein, human ; Cholesterol, HDL ; Lipase (EC 3.1.1.3) ; Phospholipases (EC 3.1.-) ; LIPG protein, human (EC 3.1.1.3)
    Language English
    Publishing date 2024-02-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-54705-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Endothelial Lipase Variant, T111I, Does Not Alter Inhibition by Angiopoietin-like Proteins.

    Sylvers-Davie, Kelli L / Bierstedt, Kaleb C / Schnieders, Michael J / Davies, Brandon S J

    bioRxiv : the preprint server for biology

    2023  

    Abstract: High levels of HDL-C are correlated with a decreased risk of cardiovascular disease. HDL-C levels are modulated in part by the secreted phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL and decreases circulating HDL-C ... ...

    Abstract High levels of HDL-C are correlated with a decreased risk of cardiovascular disease. HDL-C levels are modulated in part by the secreted phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL and decreases circulating HDL-C concentrations. A 584C/T polymorphism in
    Language English
    Publishing date 2023-08-30
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.08.18.553740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Can targeting ANGPTL proteins improve glucose tolerance?

    Davies, Brandon S J

    Diabetologia

    2018  Volume 61, Issue 6, Page(s) 1277–1281

    Abstract: Three members of the angiopoietin-like (ANGPTL) family of proteins, ANGPTL3, ANGPTL4 and ANGPTL8, are known regulators of plasma triacylglycerol levels. Recently, these three proteins have garnered considerable interest as potential targets for ... ...

    Abstract Three members of the angiopoietin-like (ANGPTL) family of proteins, ANGPTL3, ANGPTL4 and ANGPTL8, are known regulators of plasma triacylglycerol levels. Recently, these three proteins have garnered considerable interest as potential targets for therapeutically reducing plasma triacylglycerol levels and improving cardiovascular outcomes. In this issue of Diabetologia, Janssen et al ( https://doi.org/10.1007/s00125-018-4583-5 ) and Vatner et al ( https://doi.org/10.1007/s00125-018-4579-1 ) show that reducing levels of ANGPTL4 and ANGPTL8, respectively, could have the added benefit of improving glucose tolerance. Interestingly, the improvements in glucose tolerance observed in both studies, both done in rodents, were coupled with increased fat mass. These findings suggest that funnelling lipids to adipose tissue and away from ectopic sites could be beneficial and strengthen the argument for pursuing the therapeutic targeting of ANGPTL proteins.
    MeSH term(s) Angiopoietin-like Proteins ; Angiopoietins ; Animals ; Diet ; Glucose ; Insulin Resistance ; Lipid Metabolism ; Non-alcoholic Fatty Liver Disease ; Oligonucleotides, Antisense ; Rodentia
    Chemical Substances Angiopoietin-like Proteins ; Angiopoietins ; Oligonucleotides, Antisense ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2018-04-04
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-018-4604-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity.

    Kim, Hyunbae / Song, Zhenfeng / Zhang, Ren / Davies, Brandon S J / Zhang, Kezhong

    Science signaling

    2023  Volume 16, Issue 768, Page(s) eadd6702

    Abstract: The endoplasmic reticulum (ER)-tethered, liver-enriched stress sensor CREBH is processed in response to increased energy demands or hepatic stress to release an amino-terminal fragment that functions as a transcription factor for hepatic genes encoding ... ...

    Abstract The endoplasmic reticulum (ER)-tethered, liver-enriched stress sensor CREBH is processed in response to increased energy demands or hepatic stress to release an amino-terminal fragment that functions as a transcription factor for hepatic genes encoding lipid and glucose metabolic factors. Here, we discovered that the carboxyl-terminal fragment of CREBH (CREBH-C) derived from membrane-bound, full-length CREBH was secreted as a hepatokine in response to fasting or hepatic stress. Phosphorylation of CREBH-C mediated by the kinase CaMKII was required for efficient secretion of CREBH-C through exocytosis. Lipoprotein lipase (LPL) mediates the lipolysis of circulating triglycerides for tissue uptake and is inhibited by a complex consisting of angiopoietin-like (ANGPTL) 3 and ANGPTL8. Secreted CREBH-C blocked the formation of ANGPTL3-ANGPTL8 complexes, leading to increased LPL activity in plasma and metabolic tissues in mice. CREBH-C administration promoted plasma triglyceride clearance and partitioning into peripheral tissues and mitigated hypertriglyceridemia and hepatic steatosis in mice fed a high-fat diet. Individuals with obesity had higher circulating amounts of CREBH-C than control individuals, and human
    MeSH term(s) Animals ; Humans ; Mice ; Angiopoietin-Like Protein 3 ; Angiopoietin-Like Protein 8 ; Endoplasmic Reticulum/genetics ; Endoplasmic Reticulum/metabolism ; Lipid Metabolism/genetics ; Lipoprotein Lipase/metabolism ; Liver/metabolism ; Peptide Hormones/metabolism ; Triglycerides ; Cyclic AMP Response Element-Binding Protein/metabolism
    Chemical Substances Angiopoietin-Like Protein 3 ; Angiopoietin-Like Protein 8 ; ANGPTL3 protein, human ; ANGPTL8 protein, human ; ANGPTL8 protein, mouse ; Lipoprotein Lipase (EC 3.1.1.34) ; Peptide Hormones ; Triglycerides ; CREB3L3 protein, human ; Cyclic AMP Response Element-Binding Protein
    Language English
    Publishing date 2023-01-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2417226-1
    ISSN 1937-9145 ; 1945-0877
    ISSN (online) 1937-9145
    ISSN 1945-0877
    DOI 10.1126/scisignal.add6702
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.

    Sylvers-Davie, Kelli L / Davies, Brandon S J

    American journal of physiology. Endocrinology and metabolism

    2021  Volume 321, Issue 4, Page(s) E493–E508

    Abstract: Triglyceride-rich lipoproteins deliver fatty acids to tissues for oxidation and for storage. Release of fatty acids from circulating lipoprotein triglycerides is carried out by lipoprotein lipase (LPL), thus LPL serves as a critical gatekeeper of fatty ... ...

    Abstract Triglyceride-rich lipoproteins deliver fatty acids to tissues for oxidation and for storage. Release of fatty acids from circulating lipoprotein triglycerides is carried out by lipoprotein lipase (LPL), thus LPL serves as a critical gatekeeper of fatty acid uptake into tissues. LPL activity is regulated by a number of extracellular proteins including three members of the angiopoietin-like family of proteins. In this review, we discuss our current understanding of how, where, and when ANGPTL3, ANGPTL4, and ANGPTL8 regulate lipoprotein lipase activity, with a particular emphasis on how these proteins interact with each other to coordinate triglyceride metabolism and fat partitioning.
    MeSH term(s) Angiopoietin-Like Protein 3 ; Angiopoietin-Like Protein 4/metabolism ; Angiopoietin-Like Protein 8 ; Angiopoietin-like Proteins/metabolism ; Humans ; Lipid Metabolism ; Lipoproteins/metabolism ; Peptide Hormones/metabolism ; Triglycerides/metabolism
    Chemical Substances ANGPTL3 protein, human ; ANGPTL4 protein, human ; ANGPTL8 protein, human ; Angiopoietin-Like Protein 3 ; Angiopoietin-Like Protein 4 ; Angiopoietin-Like Protein 8 ; Angiopoietin-like Proteins ; Lipoproteins ; Peptide Hormones ; Triglycerides
    Language English
    Publishing date 2021-08-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00195.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Aging and plasma triglyceride metabolism.

    Spitler, Kathryn M / Davies, Brandon S J

    Journal of lipid research

    2020  Volume 61, Issue 8, Page(s) 1161–1167

    Abstract: The risk for metabolic disease, including metabolic syndrome, insulin resistance, and diabetes, increases with age. Altered plasma TG metabolism and changes in fatty acid partitioning are also major contributors to metabolic disease. Plasma TG metabolism ...

    Abstract The risk for metabolic disease, including metabolic syndrome, insulin resistance, and diabetes, increases with age. Altered plasma TG metabolism and changes in fatty acid partitioning are also major contributors to metabolic disease. Plasma TG metabolism itself is altered by age in humans and rodents. As discussed in this review, the age-induced changes in human TG metabolism include increased plasma TG levels, reduced postprandial plasma TG clearance rates, reduced postheparin LPL activity, decreased adipose tissue lipolysis, and elevated ectopic fat deposition, all of which could potentially contribute to age-associated metabolic diseases. Similar observations have been made in aged rats. We highlight the limitations of currently available data and propose that mechanistic studies are needed to understand the extent to which age-induced alterations in TG metabolism contribute to metabolic disease. Such mechanistic insights could aid in therapeutic strategies for preventing or managing metabolic disease in older individuals.
    MeSH term(s) Adipose Tissue/metabolism ; Aging/blood ; Aging/metabolism ; Animals ; Humans ; Triglycerides/blood ; Triglycerides/metabolism
    Chemical Substances Triglycerides
    Language English
    Publishing date 2020-06-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.R120000922
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

    Shetty, Shwetha K / Walzem, Rosemary L / Davies, Brandon S J

    Journal of lipid research

    2020  Volume 61, Issue 4, Page(s) 546–559

    Abstract: The hydrolysis of triglycerides in triglyceride-rich lipoproteins by LPL is critical for the delivery of triglyceride-derived fatty acids to tissues, including heart, skeletal muscle, and adipose tissues. Physiologically active LPL is normally bound to ... ...

    Abstract The hydrolysis of triglycerides in triglyceride-rich lipoproteins by LPL is critical for the delivery of triglyceride-derived fatty acids to tissues, including heart, skeletal muscle, and adipose tissues. Physiologically active LPL is normally bound to the endothelial cell protein glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1), which transports LPL across endothelial cells, anchors LPL to the vascular wall, and stabilizes LPL activity. Disruption of LPL-GPIHBP1 binding significantly alters triglyceride metabolism and lipid partitioning. In this study, we modified the NanoLuc® Binary Technology split-luciferase system to develop a novel assay that monitors the binding of LPL to GPIHBP1 on endothelial cells in real time. We validated the specificity and sensitivity of the assay using endothelial lipase and a mutant version of LPL and found that this assay reliably and specifically detected the interaction between LPL and GPIHBP1. We then interrogated various endogenous and exogenous inhibitors of LPL-mediated lipolysis for their ability to disrupt the binding of LPL to GPIHBP1. We found that angiopoietin-like (ANGPTL)4 and ANGPTL3-ANGPTL8 complexes disrupted the interactions of LPL and GPIHBP1, whereas the exogenous LPL blockers we tested (tyloxapol, poloxamer-407, and tetrahydrolipstatin) did not. We also found that chylomicrons could dissociate LPL from GPIHBP1 and found evidence that this dissociation was mediated in part by the fatty acids produced by lipolysis. These results demonstrate the ability of this assay to monitor LPL-GPIHBP1 binding and to probe how various agents influence this important complex.
    MeSH term(s) Animals ; Biological Assay/methods ; Cell Line ; Chylomicrons/pharmacology ; Endothelial Cells/metabolism ; Fatty Acids/pharmacology ; Lipoprotein Lipase/metabolism ; Orlistat/pharmacology ; Protein Binding/drug effects ; Rats ; Receptors, Lipoprotein/metabolism
    Chemical Substances Chylomicrons ; Fatty Acids ; GPIHBP1 protein, rat ; Receptors, Lipoprotein ; Orlistat (95M8R751W8) ; Lipoprotein Lipase (EC 3.1.1.34)
    Language English
    Publishing date 2020-02-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.D119000388
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Chronic high-fat feeding and prolonged fasting in liver-specific ANGPTL4 knockout mice.

    Spitler, Kathryn M / Shetty, Shwetha K / Cushing, Emily M / Sylvers-Davie, Kelli L / Davies, Brandon S J

    American journal of physiology. Endocrinology and metabolism

    2021  Volume 321, Issue 4, Page(s) E464–E478

    Abstract: Obesity is associated with dyslipidemia, ectopic lipid deposition, and insulin resistance. In mice, the global or adipose-specific loss of function of the protein angiopoietin-like 4 (ANGPTL4) leads to decreased plasma triglyceride levels, enhanced ... ...

    Abstract Obesity is associated with dyslipidemia, ectopic lipid deposition, and insulin resistance. In mice, the global or adipose-specific loss of function of the protein angiopoietin-like 4 (ANGPTL4) leads to decreased plasma triglyceride levels, enhanced adipose triglyceride uptake, and protection from high-fat diet (HFD)-induced glucose intolerance. ANGPTL4 is also expressed highly in the liver, but the role of liver-derived ANGPTL4 is unclear. The goal of this study was to determine the contribution of hepatocyte ANGPTL4 to triglyceride and glucose homeostasis in mice during a high-fat diet challenge. We generated hepatocyte-specific ANGPTL4 deficient (
    MeSH term(s) Angiopoietin-Like Protein 4/physiology ; Animals ; Diet, High-Fat ; Fasting ; Female ; Glucose Intolerance/etiology ; Glucose Intolerance/metabolism ; Glucose Intolerance/pathology ; Glucose Intolerance/prevention & control ; Insulin Resistance ; Lipid Metabolism ; Liver/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Triglycerides/blood
    Chemical Substances Angiopoietin-Like Protein 4 ; Angptl4 protein, mouse ; Triglycerides
    Language English
    Publishing date 2021-08-16
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00144.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice.

    Spitler, Kathryn M / Shetty, Shwetha K / Cushing, Emily M / Sylvers-Davie, Kelli L / Davies, Brandon S J

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 7873

    Abstract: Elevated plasma triglyceride levels are associated with metabolic disease. Angiopoietin-like protein 4 (ANGPTL4) regulates plasma triglyceride levels by inhibiting lipoprotein lipase (LPL). Our aim was to investigate the role of adipocyte-specific ... ...

    Abstract Elevated plasma triglyceride levels are associated with metabolic disease. Angiopoietin-like protein 4 (ANGPTL4) regulates plasma triglyceride levels by inhibiting lipoprotein lipase (LPL). Our aim was to investigate the role of adipocyte-specific deficiency of ANGPTL4 in mice during high fat diet feeding. Adipocyte-specific ANGPTL4 deficient mice were fed a high fat diet (60% kCal from fat) for either 12 weeks or 6 months. We performed plasma metabolic measurements, triglyceride clearance and uptake assays, LPL activity assays, and assessed glucose homeostasis. Mice lacking adipocyte ANGPTL4 recapitulated the triglyceride phenotypes of whole-body ANGPTL4 deficiency, including increased adipose LPL activity, lower plasma triglyceride levels, and increased uptake of triglycerides into adipose tissue. When fed a high fat diet (HFD), these mice continued to display enhanced adipose LPL activity and initially had improved glucose and insulin sensitivity. However, after 6 months on HFD, the improvements in glucose homeostasis were largely lost. Moreover, despite higher adipose LPL activity levels, mice lacking adipocyte ANGPTL4 no longer had increased triglyceride uptake into adipose compared to littermate controls after chronic high-fat feeding. These observations suggest that after chronic high-fat feeding LPL is no longer rate-limiting for triglyceride delivery to adipocytes. We conclude that while adipocyte-derived ANGPTL4 is an important regulator of plasma triglyceride levels and triglyceride partitioning under normal diet conditions, its role is diminished after chronic high-fat feeding.
    MeSH term(s) Adipose Tissue/metabolism ; Angiopoietin-like 4 Protein/physiology ; Animals ; Diet, High-Fat/adverse effects ; Female ; Glucose/metabolism ; Male ; Mice ; Mice, Inbred ICR ; Mice, Knockout ; Triglycerides/blood
    Chemical Substances Angiopoietin-like 4 Protein ; Angptl4 protein, mouse ; Triglycerides ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2021-04-12
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-87020-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.

    Sylvers-Davie, Kelli L / Segura-Roman, Ashley / Salvi, Alicia M / Schache, Kylie J / Davies, Brandon S J

    Journal of lipid research

    2021  Volume 62, Page(s) 100112

    Abstract: High plasma triglyceride (TG) levels and low HDL-C levels are risk factors for atherosclerosis and cardiovascular disease. Both plasma TG and HDL-C levels are regulated in part by the circulating inhibitor, angiopoietin-like 3 (ANGPTL3). ANGPTL3 inhibits ...

    Abstract High plasma triglyceride (TG) levels and low HDL-C levels are risk factors for atherosclerosis and cardiovascular disease. Both plasma TG and HDL-C levels are regulated in part by the circulating inhibitor, angiopoietin-like 3 (ANGPTL3). ANGPTL3 inhibits the phospholipase, endothelial lipase (EL), which hydrolyzes the phospholipids of HDL, thus decreasing plasma HDL levels. ANGPTL3 also inhibits LPL, the lipase primarily responsible for the clearance of TGs from the circulation. Previous studies have shown that ANGPTL3 requires complex formation with the related ANGPTL protein, angiopoietin-like 8 (ANGPTL8), to efficiently inhibit LPL, but the role of ANGPTL8 in EL inhibition is not known. In this study, we characterized inhibition and binding of EL by ANGPTL3 and investigated the role of ANGPTL8 in EL inhibition. We found that inhibition of EL by ANGPTL3 was dose dependent and temperature dependent. Interestingly, this inhibition was diminished when EL was bound to endothelial cells or in the presence of heparin. Unlike previous findings with LPL, we found that ANGPTL8 did not significantly alter the binding or the inhibition of EL by ANGPTL3. In addition, we found that a common ANGPTL8 variant, which encodes an R59W mutation, altered the ability of ANGPTL3 to bind and inhibit LPL but not EL. Together, our data indicate that ANGPTL8 is not necessary for EL inhibition. We conclude that ANGPTL8 is specific for the regulation of TG-rich lipoproteins through the LPL pathway and that therapeutically targeting ANGPTL8 for the treatment of hypertriglyceridemia or cardiovascular disease may have different outcomes than targeting ANGPTL3.
    MeSH term(s) Angiopoietin-Like Protein 3/metabolism ; Angiopoietin-Like Protein 8/metabolism ; Animals ; Cell Line ; Endothelial Cells/enzymology ; Humans ; Lipase/metabolism ; Mice ; Rats
    Chemical Substances ANGPTL8 protein, mouse ; Angiopoietin-Like Protein 3 ; Angiopoietin-Like Protein 8 ; Angptl3 protein, mouse ; Lipase (EC 3.1.1.3)
    Language English
    Publishing date 2021-08-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1016/j.jlr.2021.100112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top